Tuberculosis
Researchers explore role of co-infections in long COVID symptoms
Rapporteret af AI Billede genereret af AI Faktatjekket
A team of microbiologists suggests that infections occurring alongside SARS-CoV-2 may contribute to some cases of long COVID, potentially by reactivating latent pathogens such as Epstein–Barr virus or altering the course of tuberculosis. Their perspective, published in eLife, stresses that this remains a hypothesis and calls for large studies and better animal models to test whether these co-infections help drive persistent symptoms like fatigue and brain fog.
Scientists at the University of Basel have developed a novel testing method to determine whether antibiotics actually eliminate bacteria or merely halt their growth. This approach, called antimicrobial single-cell testing, tracks individual bacteria under a microscope to assess drug effectiveness more accurately. The findings, published in Nature Microbiology, highlight variations in bacterial tolerance to treatments for tuberculosis and other lung infections.
Rapporteret af AI
Egypt’s Health Minister Khaled Abdel Ghaffar met with a delegation from Clinilab, the authorised commercial partner of Germany’s QIAGEN in Egypt, to discuss bolstering public-health diagnostic and surveillance capacities. The talks focused on expanding the national tuberculosis (TB) testing and monitoring programme, alongside water network surveillance. Discussions also covered scaling up rapid tests for respiratory, gastrointestinal diseases, and meningitis.